Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy
about
Regulation of Natural Killer Cell Function by STAT3Melanoma Cancer Stem Cells: Markers and FunctionsTumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.Immunotherapy for malignant mesothelioma: Reality check.Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.
P2860
Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Integrating Immune Checkpoint ...... nical Outcome of Immunotherapy
@ast
Integrating Immune Checkpoint ...... nical Outcome of Immunotherapy
@en
Integrating Immune Checkpoint ...... nical Outcome of Immunotherapy
@nl
type
label
Integrating Immune Checkpoint ...... nical Outcome of Immunotherapy
@ast
Integrating Immune Checkpoint ...... nical Outcome of Immunotherapy
@en
Integrating Immune Checkpoint ...... nical Outcome of Immunotherapy
@nl
prefLabel
Integrating Immune Checkpoint ...... nical Outcome of Immunotherapy
@ast
Integrating Immune Checkpoint ...... nical Outcome of Immunotherapy
@en
Integrating Immune Checkpoint ...... nical Outcome of Immunotherapy
@nl
P2860
P356
P1433
P1476
Integrating Immune Checkpoint ...... nical Outcome of Immunotherapy
@en
P2093
Cristina Maccalli
Giorgio Parmiani
P2860
P304
P356
10.3390/VACCINES3020420
P407
P50
P577
2015-01-01T00:00:00Z